A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancerXiaoyan Si, Li Zhang, Liying Cui et al.|Therapeutic Advances in Medical Oncology|2020Cited by 15
[Responses of advanced esophageal cancer to chemotherapy and prognostic factors: a report of 138 cases].Aina Liu, Jinwan Wang, Jing Huang et al.|PubMed|2008Cited by 1